Does TELMISARTAN Cause Therapy non-responder? 31 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Therapy non-responder have been filed in association with TELMISARTAN (telmisartan). This represents 0.5% of all adverse event reports for TELMISARTAN.
31
Reports of Therapy non-responder with TELMISARTAN
0.5%
of all TELMISARTAN reports
2
Deaths
14
Hospitalizations
How Dangerous Is Therapy non-responder From TELMISARTAN?
Of the 31 reports, 2 (6.5%) resulted in death, 14 (45.2%) required hospitalization, and 3 (9.7%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which TELMISARTAN Alternatives Have Lower Therapy non-responder Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS